1. Home
  2. SHFS vs CMND Comparison

SHFS vs CMND Comparison

Compare SHFS & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SHF Holdings Inc.

SHFS

SHF Holdings Inc.

HOLD

Current Price

$0.48

Market Cap

2.7M

Sector

Finance

ML Signal

HOLD

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

HOLD

Current Price

$3.70

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHFS
CMND
Founded
2015
2017
Country
United States
Canada
Employees
41
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7M
2.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SHFS
CMND
Price
$0.48
$3.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
220.4K
1.4M
Earning Date
04-15-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$0.07
52 Week High
$9.18
$3.25

Technical Indicators

Market Signals
Indicator
SHFS
CMND
Relative Strength Index (RSI) 39.13 82.25
Support Level $0.38 $0.31
Resistance Level $0.96 N/A
Average True Range (ATR) 0.05 0.25
MACD 0.01 0.31
Stochastic Oscillator 66.72 79.05

Price Performance

Historical Comparison
SHFS
CMND

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Share on Social Networks: